{
    "title": "US FDA approves Pfizer RSV vaccine a month after greenlighting GSK shot",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11650181/Moderna-data-puts-spotlight-RSV-vaccines-development.html",
    "date": "2023-01-18",
    "keywords": [
        "vaccine",
        "rsv",
        "latestage",
        "study",
        "respiratory",
        "disease",
        "year",
        "drug",
        "virus",
        "shot",
        "regulator",
        "trial",
        "month",
        "health",
        "authorization",
        "company",
        "sanofi",
        "astrazeneca",
        "merck",
        "reporting",
        "june",
        "wednesday",
        "food",
        "coldlike",
        "illness",
        "hospitalization",
        "market",
        "following",
        "list",
        "fda",
        "abrysvo",
        "use",
        "arexvy",
        "season",
        "october",
        "messenger",
        "rna",
        "cough",
        "fever",
        "application",
        "approval",
        "mrna1345",
        "quarter",
        "nirsevimab",
        "march",
        "efficacy",
        "tract",
        "placebo",
        "review",
        "co",
        "inc",
        "clesrovimab",
        "nordic",
        "april",
        "mid2023",
        "raghav",
        "mahobe",
        "srinivasan",
        "mariam",
        "khushi",
        "mandowara",
        "bhanvi",
        "satija",
        "syamnath",
        "sriraj",
        "kalluvila",
        "shounak",
        "dasgupta",
        "maju",
        "samuel",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}